J. Bradley White J. Bradley White

Mylan Pharmaceuticals ULC in its patent litigation victory against Eli Lilly

In ongoing litigation lasting years, Osler has been representing Mylan Pharmaceuticals ULC in defence of an action for patent infringement brought by Eli Lilly in relation to the blockbuster drug Tadalafil (Cialis). In 2020, Osler successfully defended Mylan Pharmaceuticals ULC in an action...

Lead Office: Toronto Date Closed: June 2, 2023 Value: -

Teva Canada in the Federal Court’s strike of judicial review by Novo Nordisk Canada Inc.

In 2019-2020 Osler successfully represented Teva Canada in a judicial review application brought by Novo Nordisk Canada Inc. in respect of a decision of the Minister of Health concerning Teva’s drug submission for liraglutide. The application was struck, providing a...

Lead Office: Toronto Date Closed: -- Value: -

Teva Canada in its successful patent proceeding

In May 2020, Osler successfully represented Teva Canada in a multi-party patent proceeding. The case involved the drug rivaroxaban (XARELTO), a significant product with significant sales in Canada. The trial judge ordered a common hearing of Teva’s case which would have negated...

Lead Office: Toronto Date Closed: May 1, 2020 Value: -

Federal Court Rules in favour of Mylan Pharmaceuticals ULC in an anti-inflammatory combination drug patent case

Osler successfully represented Mylan Pharmaceuticals ULC in a patent proceeding brought by pharmaceutical company AstraZeneca. On February 7, 2017, the Federal Court of Canada issued a decision in AstraZeneca Canada Inc. v Mylan Pharmaceuticals ULC, 2017 FC 142 that invalidated the...

Lead Office: Ottawa Date Closed: February 7, 2017 Value: -

Mylan Pharmaceuticals in a patent proceeding brought by Amgen

Osler successfully represented Mylan Pharmaceuticals in a patent proceeding brought by pharmaceutical company Amgen to prohibit the Minister of Health from issuing a market authorization (notice of compliance) to Mylan for its generic version of the drug SENSIPAR^® (cinacalcet...

Lead Office: Ottawa Date Closed: November 3, 2015 Value: -

Federal Court Rules in Favour of Mylan Pharmaceuticals ULC in Pantoprazole Magnesium Patent Case

Osler successfully represented Mylan Pharmaceuticals in a patent proceeding against pharmaceutical company Takeda to prohibit the Minister of Health from issuing a market authorization (notice of compliance) to Mylan for its generic version of the drug TECTA®...

Lead Office: Ottawa Date Closed: June 15, 2015 Value: -